Greetings. Welcome to the Helen of Troy Limited First Quarter Fiscal 2021 Earnings Call. At this time, all participants today will be in a listen-only mode. A brief question-and-answer session will follow the formal presentation. [Operator Instructions] Please note this conference is being recorded. I will now turn the conference over to Jack Jancin, Senior Vice President of Corporate. Sir, you may begin.

Thank you, operator. Good morning, everyone and welcome to Helen of Troy’s first quarter fiscal 2021 earnings conference call. The agenda for the call this morning is as follows. I will begin with a brief discussion of forward-looking statements. Mr. Julien Mininberg, the company’s CEO, will comment on some high-level results for the quarter and discuss current business trends. Then Mr. Brian Grass, the company’s CFO will review the financials in more detail and reflect on considerations from the ongoing COVID-19 pandemic uncertainty as fiscal year ‘21 progresses. Following this, we will open the call to take your questions. This conference call may contain certain forward-looking statements that are based on management’s current expectation with respect to future events or financial performance. Generally, the words anticipates, believes, expects and other words similar are words identifying forward-looking statements. Forward-looking statements are subject to a number of risks and uncertainties that could cause anticipated results to differ materially from the actual results. This conference call may also include information that maybe considered non-GAAP financial information. These non-GAAP measures are not an alternative to GAAP financial information and maybe calculated differently than the non-GAAP financial information disclosed by other companies. The company cautions listeners not to place undue reliance on forward-looking statements or non-GAAP information. Before I turn the call over to Mr. Mininberg, I would like to inform all interested parties that a copy of today’s earnings release has been posted to the Investor Relations section of the company’s website at www.helenoftroy.com. The earnings release contains tables that reconcile non-GAAP financial measures to their corresponding GAAP-based measures. The release can be obtained by selecting the Investor Relations tab on the company’s homepage and then the News tab. I will now turn the conference call over to Mr. Mininberg.

Thank you, Jack. Good morning, everyone, and thank you for joining us. This morning, we reported an excellent quarter, with net sales growth of 11.8% and adjusted EPS growth of 22.8% versus a year ago. All three business segments performed well above our expectations. Many of the positive trends we highlighted in April accelerated as the quarter progressed and outweighed the unfavorable trends we discussed. The benefits of our diversified portfolio of brands, online capability, strong shared services and our highly committed organization showed very well as we adapted quickly to the tremendous challenges from COVID-19 and we are able to be there for consumers when they needed us most. Collectively, our eight leadership brands grew sales at 15.7% in the quarter, led by double-digit growth from all of Health & Home’s leadership brands: Vicks, Braun, PUR and Honeywell. These brands benefited from very strong demand for our highly trusted health and wellness related products. OXO also grew nicely in the quarter as consumers spent much more time at home. Hydro Flask sales declined amid store closures, but performed better than we expected. Hot Tools grew sales despite store and salon closures. Channel mix played a particularly important role as lockdowns kept families home to varying degrees around the world. Online capability development has been a key strategic focus for both Phase 1 and Phase 2 of Helen of Troy’s transformation, growing roughly four-fold since 2014 to reach 24% of total company sales at the end of fiscal ‘20. In this quarter, online grew a further 33%, now representing 28% of consolidated sales as even more consumers moved from bricks to clicks. We also performed better than expected in those brick and mortar stores that remained open. International performance was a standout in the quarter, growing faster than total company…

Thank you, Julien. Good morning, everyone and thank you for joining us. I hope that you are all safe and healthy. Our thoughts continue to be with the people who’ve been directly affected by the COVID-19 pandemic as well as the first responders, healthcare workers, medical providers and essential workers who are on the front lines. We want to extend our appreciation for their efforts and for the efforts of our own associates that aren’t able to work from home. Our priority has been and continues to be the well-being of our associates, customers and business partners during this unprecedented time. More recently, acts of violence have underscored the racial inequity that exists in our country. As Julien mentioned, we are further advancing the cultural changes we first embarked upon six years ago to put greater emphasis on inclusivity and diversity and to promote greater equality across our company. We are also supporting organizations that we believe can have an impact in our communities and across the world. I could not be prouder of the company and how it is responding in these difficult times. Now turning to our results for the first quarter, we began the year with better than expected results despite operating under unprecedented conditions. Our diversified portfolio and strategies to maximize the strength of our Leadership Brands, accelerate our omnichannel excellence and drive international growth served us well, fueling double-digit sales growth. This, combined with the temporary expense reduction measures we took during the quarter, resulted in healthy margin expansion and adjusted diluted EPS growth of almost 23%. We also remain steadfast in our focus on fiscal discipline, ending the quarter with $1.1 billion in liquidity, including $88.5 million in cash and cash equivalents, $930 million available on our $1.25 billion credit facility. We generated $86…

[Operator Instructions] And our first question comes from the line of Bob Labick with CJS Securities. Please proceed with your question.

Good morning and congratulations on a terrific start in a quite a difficult environment.

Thank you. Good morning, Bob.

Great. So I wanted to start you gave us a little bit of color, and it’s appreciated on the Health & Home, but maybe you could talk a little more about some of the trends within the segment and from the leadership brands and more specifically about some of the innovations you maybe driving right now to make some of this growth sustainable over a medium or longer term?

Yes, great. Thanks, Bob, and hi, Julien here. Innovation is a big deal at Helen of Troy. We have got eight leadership brands. It’s the lifeblood of any strong brand and fiscal ‘21 and no exception. In Health & Home, there is a slew of new products in all the key categories under development, some launching this year and in a very rich pipeline over the next three fiscal years. And we are investing in it there and across the other business units as part of the transformation despite the COVID-19 light switch work earlier in the year and now leaning in further with additional funds with the announcements that we are making today. When it comes specifically to other business units beyond Health & Home, there is two or three pretty big things going on. One is that OXO continues to invest heavily in its pipeline. That is been a traditional strength of that brand for all 30 years of its 30-year history. And Hydro Flask has a significant pipeline, some of it even beyond the bottle that we have been working on and are bringing to the market with speed. When it comes to Beauty, the volumizer franchise is one that we’ve already proven that we can expand beyond the original innovations from our global organization there. It is globalizing. There is many variants now for us. That franchise and now across the full brand portfolio – and it is not just volumizers. There is other areas; straightening, curling irons and some other specialty products that we have our pipeline work going on in Beauty, and that’s getting funds, attention and additional people. Drybar is also getting a new prestige focus for us given the acquisition and expands our innovation focus there. There it also goes beyond tools to also liquids, which is so important to Drybar. We are very tuned into what the stylists want. I mean, we have 3,000 frontline people in those salons who are giving us feedback all the time on what’s the right next thing to appeal to the prestige market and uniquely for Drybar. And the last big one is international where Helen of Troy has chosen double down on international as a key strategy, and there are some significant work on the pipeline side going on to make sure that we have product lines that are correct overtime for the multi-regional aspirations we have and the consumer to have differences in those regions, so big deal, big investment and lots of ways to keep growing through innovation.

Great. Very appreciated. And one, just out of kind of curiosity and excitement, and personal even, as it relates to Hydro Flask, I know you have a customization initiative, and I was wondering how much that may have been impacted so far by the pandemic, and where you stand on that? When we may see increase in customization from Hydro Flask?

Yes. So, this is a key area for us and one where frankly I think we are a bit behind. We have amped this up and it definitely does go slower during COVID. Our front-line and market-facing people are very focused on all of the challenges that go with COVID. Just think of getting product out the door, meeting the demand, big, big surges, like on fire kind of surges in online and direct to consumer in that way. So there was less customization. Now, we are amping this up and now are spending even more on it. So I wish I could tell you by date X, you’re going to get capability Y. But suffice to say that customization is strategic for Hydro Flask. It’s one of those eight or nine major long-term factors that we’ve cited several times as growth drivers, and there is more of it now, more of it coming, and it’s a big focus for Hydro Flask.

Got it, great. Okay. Last one from me, I promise. You mentioned the sale of Personal Care is ongoing, I was wondering if you could talk more about an update on the M&A environment in general and more offensive potential M&A, given your tremendous cash flow and balance sheet right now, and where that stands as it relates to COVID and the pandemic, and are you able to look at things, etcetera?

Hey, Bob, it’s Brian. I think I can start and then maybe if Jack or Julien want to add on. I think what it’s done, I think it’s limited potential opportunities or at least made it harder to evaluate potential opportunities because the environment is so uncertain and acquisitions have a level of uncertainty and that type of thing in them already. And so you layer on an environment like this, I think it makes it difficult to get comfortable with acquisitions. And I think there is less of a pool that you are excited about in terms of an attractive asset. But having saying that, there are assets out there that are attractive and we are looking at a couple right now. So to me, that’s encouraging that in such an uncertain environment, we can still get our hands on some attractive assets and potentially work towards a deal. So I am encouraged by that. It’s really hard to do things like due diligence and go visit targets in this environment, and that’s been really limited. But if I had to weigh it all together, I would say, overall, I am encouraged that at least we have some attractive assets that we’re kicking around at the moment. Jack, you want to add?

I am not sure I really have much to add. I think Brian characterized it right. Our criteria still remains, we’re disciplined about it. We do have to find different ways to go and evaluate and diligence. But there are a couple of attractive assets that we are looking at right now, and understand there could be more that come out over the next year. So we will wait and see for those. But we are actively pursuing a couple of things. It’s just – we’ll have more to say if they look attractive after we get a chance to do the type of diligence we need to do in order to consummate a transaction.

Yes. Two quick build from my view. One is that there is likely to be some interesting new prospects as the COVID pandemic shakes out. It’s probably a little early for that, to see how all of it plays out, but it can expose some very interesting assets to a set of strategic alternatives for them that they may not have considered before and that could be attractive for us as a strong player in the industry, as we just demonstrated today, it turns out, one with enough firepower. And the second comment from me is on the subject of firepower. You saw a lot of cash generated in the quarter, our debt coming down, you know about our new revolver that we announced earlier in the calendar year, and it gives us the firepower to act when we can do the diligence when a target is right and when we’re ready.

Alright, terrific. Thank you very much and congratulations, again, on a fantastic quarter.

Thanks Bob.

Thanks Bob.

The next question is from the line of Rupesh Parikh with Oppenheimer. Please proceed with your questions.

Good morning. Thanks for taking my question. Also congrats on a great quarter.

Thank you.

So maybe I guess I will start first with the supply chain. I know last quarter you had some challenges on the supply chain with I think thermometers and also the volumizer product. I am just curious right now where you guys are from a supply chain perspective in key categories.

Yes, let me start this and Brian may have some builds. Supply had been a big challenge for us coming through Q4 of last year and into Q1. There are still some areas, including thermometers and some in Housewares where we are building back. So, but we’ve caught up a ton and we just demonstrated that we can meet a lot more demand as it comes in. So let me try to go through them category by category. There is a good news in thermometers. We increased capacity, as we mentioned in the prepared remarks, during the quarter, and we are able to do that in very short timing. That said, it’s not enough to meet all the demand we are facing. And if we could make more, we would definitely sell more. The demand is that big. And going forward on thermometers, we are now adding additional capacity, and that new capacity will come online in good timing with the upcoming cold and flu season, and it gives us an opportunity to make and sell more later in the year. In the case of volumizers, we did catch up. And so you saw that we shipped all that we could make during the quarter. We said that in our remarks. In April, it happened, and then we have added significantly the supply and we are shipping to demand much more closely. We also saw our share grow as a result of that, and that helped. And when it comes to Housewares, especially OXO, we are facing some out of stocks because of the demand surge from the home and nesting trend and the stores that remained open also had significant sales beyond the online surge, and that led to some out of stocks. If you look at that one, we will be okay. We are bringing in more supply now, but there will be some out of stocks for the period in between. And the last thing I would say is that there is kind of a triple whammy going on. So you might think why are we in this situation. The triple whammy is that in Q4, you remember, we had more sales than we expected and as a result sold down an amount of our inventory. In Q1, we saw the shutdown in China from COVID-19 right around Chinese New Year and for all suppliers that were China based in these products, the China supply was simply stopped for a while. So we were depleted and then faced less replenishment. Then the third part of the whammy was COVID in the categories that we just discussed, where there were simply more demand and where at the time we had less supply. So, that’s why the crunch where we stand and a little bit about looking forward. Brian, you may have some views on the supply side?

No. Just put some numbers around – we also grew 15% in the fourth quarter. And then, as Julien mentioned, Chinese New Year and COVID right on top of each other. And then we’ve grown close to double digits in the first quarter. And you kind of put all of that together, and that is something that would have been difficult to plan for perfectly. But as Julien said, it is not like we don’t have supply coming in. We do have supply coming in. We are just chasing the demand, which is a good problem to have.

Okay, great. That’s helpful color. And then just going back to retail store re-openings, I know you guys provided a fair amount of color in terms of what you are seeing. But is my interpretation correct that at this point you look at these stores that are reopened and maybe results are not back to pre-coronavirus trends. And as you look at these spikes in infections in different markets, are you guys seeing more volatility in these customers that have recently reopened stores?

Yes, it is a little too soon to say, and it is a great question because it gives you a sense as to what’s happening in real time. It depends a ton by chain, by region and by category. So I’m sorry for such a loose answer, but it is too soon and it does depend. A little color may help here. As people went back to stores, there was some pent-up demand. I just think they wanted to buy and now they could go to the store and they have bought them if they hadn’t already done so online. So that helped in there. Consumer behavior is a little rough in the stores. You probably have seen lots of reports about stores where people were asked to wear masks, they didn’t want to wear the masks, the stores didn’t want to make them feel uncomfortable about being there with or without the mask. It’s too messy and a little rough in that environment. I think that’s since gotten fairly well sorted. And this concept of, if you are out in public, you need a mask is becoming a national truth and people are simply doing that. So people feel more comfortable in their behavior and also other people know that that’s the case, and therefore themselves more comfortable, so there is self reinforcement in that regard. Good also for the frontline workers in the store, so they show up and do their jobs. And in terms of the store traffic, it is just too soon to know, I think is the easiest way to say it, but I can’t say that people are shopping again in stores or shipping and they’re also ordering. And region-by-region, state-by-state, there is so much news every week to venture on that one. Probably some stores that are closing too, and you see a little bit of that. And so, there’ll be some openings and some re-closings. There will just be a lot of chatter for the next couple of months as that gets sorted. I mean, Brian’s got some build.

Yes, I mean just to, I think if you want a headline or takeaway, I think stores in general are going to be a net positive to most of our businesses going forward from this point, because, what’s really reopened has been the slow build. So I don’t think we’ve seen a lot of benefit from that yet, and – should grow and expand from here and the majority of our retailers have taken it slow. They have wanted to reopen safely and make consumers feel safe. And so, I think that’s going to continue to build. With respect to stuff reversing in closing again, I mean we have seen recent outbreaks, Arizona, Arkansas, California and North Carolina, South Carolina Tennessee and Texas, and out of all of that what we have seen in terms of reclosing is there were 10 Sephora stores that re-closed in the Houston area only. So that’s pretty isolated. For Health & Home, no current store closures to report there. And then in Housewares, DICK’s Sporting Goods has stated that they would only close stores based on city and state requirements going forward. Bed, Bath & Beyond, you may have seen today is closing 200 low performing stores, but that is not COVID related. And just from – so from – for some perspective on those stores, they were low performing and we don’t believe they’re going to impact our point-of-sale very much at all. We’ve already analyzed the stores and we feel good about that. And then you may have also seen that sort of the top filed for Chapter 11, which is probably partially COVID related, but not really a safety thing. And so that that’s probably the extent of closures that we know about at this point, but we are cautious about the spike in infections and what that will do in the future, which is one of the reasons why we didn’t feel like we can give an outlook.

Okay, great. Thanks for your thoughts.

That’s just really what it comes down to, even if it’s choppy for a while.

Okay, great. Thank you.

The next question is from the line of Olivia Tong with Bank of America. Please proceed with your question.

Right. Thank you. Good morning.

Hi.

Why don’t you talk a little bit about obviously sales first, because, those numbers are quite a bit stronger than I think many of us expected across the board. So wanted to get a sense of what you’re seeing across the major divisions and what your expectations are assuming retail is opened, but viruses – virus cases continue to rise, like in Housewares? What you think that does for Hydro Flask? Does OXO continue to outperform, but obviously not necessarily as well as it did in this quarter? And then what does that mean for Housewares margins going forward, because obviously you saw a very big divide between what OXO did versus what Hydro Flask did in this quarter? Thanks.

Yes. It is a great question, and hi, Olivia. Hydro Flask held up surprisingly well compared to what we expected during Q1, and that said was down, and it does affect the mix, to your point about margin within Housewares and also therefore on a consolidated basis. But nevertheless the Health & Home was big enough to more than counteract both in mix and margin and up they went on the gross margin and also operating margin basis. So good from a diversified portfolio standpoint, and even diversified within Housewares, I think of indoor and outdoor just to make it as simple as possible, OXO and Hydro Flask and people are more indoors, so more indoor stuff, people who are less outdoors, we sold less outdoor stuff. In the case of now with the stores reopening, it is a net positive for Hydro Flask to your question. As Brian mentioned in his prepared remarks, we have seen a significant rebound in Hydro Flask, we like very much what has happened so far in Q2 and we like the trend at the end of Q1. Once some stores start reopening but mostly the essential status are opening at places like Amazon, which were online. Hydro Flask responded beautifully, the minute that happened. And we like that quite a lot. And in terms of margin mix going forward, Hydro Flask is one of our best margin brands, above not only fleet average, but to your point, above the Housewares average. So in terms of margin expectations within Housewares, the balancing of more Hydro Flask regardless of what OXO does will be a good guy for the margin mix within Housewares and therefore fleet average of the company. And as for the stores and the activities, as Brian mentioned in his remarks, there is just a couple of good trends going on. One is in the northern hemisphere at summer time, people are outside more. There is a lot more activity of hike and bike and all of that. There is a bit of a trend going on with this idea of solitary adventurism. So think of people who are wanting to go out on their – want to go out, preferring to stay a bit more away from others. And so they might take at hike or bike on their own camping, things like this that Brian mentioned all those things are good for Hydro Flask, good for people soles and the stores are opened and they are good for sales.

Got it. Thanks. It’s helpful. Maybe a little bit more on the margin, just some clarification because, especially for fiscal Q2 since you have that one-off tariff benefit last year, are you saying that you expect the reinstatement of spending, some higher investments, etcetera., is going to result in operating margins being down going forward? Or that you just assume operating expansion will decelerate as the year progresses because of that reinstatement of spending?

Let me ask Brian.

Yes. We are almost halfway through the second quarter. And so a lot of the things we have talked about reinstating are only going to be in the back half of the quarter. So I would say that we expect margins to hold up fairly well in the second quarter year-over-year. Where – we are expecting some margin compression potentially is in the back half of the year and that’s really going to depend on what investment choices we make, and that’s really going to depend on what revenue we are seeing. So there’s a lot of moving parts and it’s hard to tell you what the exact equation will be between the revenue and the margin, because we’ll make choices based on the revenue, which is going to affect margin, but we don’t know what choice we are going to make until we have a better picture of the revenue. All signs are going in the right direction at the moment with respect to revenue in terms of, we were expecting – we have no expectations for the market and the consumer going into this and I think things have proven out to be better and then have been getting better as we went. And so hopefully we are ahead of it, and then we can see how it plays out and revenue gets better and then we can continue to play offense, which is what we are trying to do making investments each time we have more clarity and revenue gets a little bit better. So I know it’s not a perfect answer, but if I was going to expect anything I would expect pressure on the margins year-over-year in the second half of the year.

Got it. That’s helpful. Two last ones. First in Health & Home, you talked about increased capacity already can you just put some numbers around how much you have increased capacity already? And what you are preparing for assuming that we do have a more substantial wave of cases in the fall-winter and obviously preparation for just regular cold and flu as well? What conversations you have had with your retailers in terms of expected increase in purchasing? And then on Beauty, you made some comments earlier about the M&A environment and how it’s difficult to do due diligence and all these other things from a acquisition perspective. So can you just talk about that from the lens of, you guys trying to divest the personal care business and how those conversations are going as well? Thanks. That’s it for me.

Sure. Let’s start with the second one, just because, I think it’s top of mind for a number of people on the divestiture. We are in a point in the process where it’s not – we are not yet ready for the deep diligence from potential buyers. There is outreach, there is inbound, there is material, there is advisor that’s been hired. We are doing all the right things. We said in our prepared remarks that the process is ongoing, the marketing as been done. So we are not at the stage yet, where we have run into a roadblock. There is an assumption that it’s not necessarily for sure, that over time as COVID plays through and people do more virtual and travel and all that, there will be easy, not only for us on the acquisition side, but to your point, our potential buyers as that process unfolds to do their work. And so I don’t know if that will slow us down yet or not. I can also say that the prospects, so far so good, but it’s too early to make any declarations. Brian, I think as a build on the divestiture and I think we can go to the supply.

Yes. Olivia, with respect to the asset that we are selling, I mean, it lines up fairly well with the environment that we are in. It’s more of a defensive product line and I think that that serves it well in this environment and we have had solid interest in the asset. And, as you know, we have been through the process before and so we are not starting from ground zero and have good connections with potential buyers. And we have – like some of them may have already diligence before and so the whole diligence roadblock that you are talking about limitation, I think we are set up to have that be less of an impact with respect to this particular asset, because we have been through the process before. We have a set of buyers who are interested and there’s familiarity with it in less need to do as much due diligence. Now, of course, we announced new people that will have to get comfortable, but it’s not just broad group of people that have to go through the complete process.

Got you. Good, and then on your supply question Olivia, and specifically around thermometers in the upholding – coming cold and flu season. It’s a little complicated. So I’ll try to simplify as easy as I can. I mean, let’s look at the supply side, and then the demand side. On the supply side, I would think in three buckets. Stuff that’s made in China, stuff that’s made in Mexico, stuff that’s made in United States. In China, there is a number of our thermometers which you are asking about specifically. In Mexico, there are certain thermometers especially the ear thermometer which is our flagship and our biggest volume item from a dollar standpoint, millions of millions of units as well. And then in the United States, the probe covers that go with the ear thermometers both for us and for our major professional customer, Welch Allyn. And so those are those supply buckets. If you look inside each of one of those, you will see that supply as increased considerably in China, as that triple whammy of post-COVID shut down comes back online. We have also increased the capacity there and are simply getting more thermometers. We plan to have that increase again as the year plays out. In Mexico, we have made some pretty big investments to increase the number of the thermometers that are coming through. That is occurring. That said, those factors are not immune to COVID from a workers’ standpoint, plenty of COVID in Mexico. So it actually can be a setback for an increased capacity line to produce all of that increased capacity. And then when it comes to the Mexican supply we are making additional investments, some big ones that should further increase supply by a fair amount, but that will take some…

Thank you, guys. Appreciate it.

Sure. Thank you.

Our next question is from the line of Linda Bolton-Weiser with D.A. Davidson. Please proceed with your questions.

Hey, Linda.

Hi. In the Beauty segment, I think you mentioned that volumizer growth, you had caught up with demand in terms of supply of volumizers. But I think you did mention that there was some product that was in short supply and you were constrained by that in Beauty. Can you just elaborate on what that was?

The comments about being constrained, was for the first quarter. We are now looking forward in a good supply position. So, we got into a good supply position at the beginning of June. But for the bulk of the quarter or almost all the quarter we are chasing demand for volumizers in Beauty. So that was the comment. The comment about being constrained was Q1. The comment about being in a good supply position is Q2 and going forward.

Great. Thanks for that clarification. And then is there any way that you can quantify how far below normal your investment spending was in the quarter and then some kind of delta between the level in the first half versus what you may anticipate in the second half?

I think it’s hard to quantify because what’s normal and we have done a lot of things going on where we need to get to a normalized level of spend and then we have additional investments that we had on tap that we want to make. We believe we have identified the right investments to make. The question is really going to be about timing. How quickly we lean in and how much of that spending will occur in fiscal ‘21 and then maybe how much of that will fall to ‘22? We would like to spend as much as we can of the investments we have identified and we are basically going to be light on that for the first half of the year, which means if you want to spend them in fiscal ‘21 you would have to double up almost in the back half of the year. I’m not sure that’s what will happen, again, our spending will be based on our revenue and our revenue is still very murky at this point for the rest of the year as it is, I think for almost anyone in our position. And so to give you something more absolute I think it’s difficult. I tried to make it is as something finite that you could latch on to as possible and saying that, look, we expect margins to maybe be compressed, and we are not talking full percentage points and things like that. We are talking tenths of a percentage point, in the two-tenths of a percentage point, things like that over the balance of the year, as we try to make up for the period of time where we were light on our spending for good reason. We needed to see how the environment played out and how the quarter played out before we could make some of those choices and we are now doing that and you will see some of it in Q2, but the bulk of it will be in Q3 and Q4.

Yes. For framework it may help here Linda is to think in terms of multi-year transformation. So as we went through our strategy reviews last December, ahead of the planning cycle for this fiscal year, it was very clear that there was a set of meaningful investments that were bold and right for fiscal ‘21 for Helen of Troy and we were not afraid to budget them and we were ready to act and we are all prepared. Given COVID and this pullback with the lights which is and all of that that’s spending has slid to the right on our timelines. Building on what Brian has said as we lean back in now with the announcements that we are making today that will have some compression effect on the back half. But net for the year, we will get what we think is the majority of those investments made, which sets us up very well for fiscal ‘22 and fiscal ‘23, in terms of the things that we listed, supply diversification in Asia, IT, direct-to-consumer customization of these kinds of things. These are big deals for Helen of Troy we must invest. Not only that supporting our leadership brands and the innovation comments that were made earlier in the Q&A section. These are all bold and they are alright. In the case of how much we get on this titration as the year plays out because of fog of COVID, I think we have demonstrated that we are fairly nimble on this and as we have funds that are not yet fully committed, we will watch super close and just make our choices in real time on what we do and don’t do to get the balance right and make sure that we are sensitive to what’s going on in the market.

Just a quick add. I mean the way I look at it is, we are up a percentage point for the first quarter. If we ended up with flat margins year-over-year for the full year, we were fortunate to get to that position. I consider that a win. And so that’s kind of the way we are trying to look at it. And Julien said, we will spend the bulk of the investments this year. I think the qualification though on that is, if the revenue is there, if things start to go in a different direction from a revenue perspective, we are going to adjust accordingly. But he’s right if revenue keeps going in the direction that it is, that is our plan.

Thank you. That’s very helpful. Congratulations.

Thank you.

Thanks, Linda.

The next question is from the line of Steve Marotta with CL King. Please proceed with your question.

Good morning, Julien, Brian and Jack. I only have one question. I’ll take the others offline. Brian, I just wanted to verify, you said earlier in the call, in your commentary that you expect moderation of Q1 demand in Health & Home and then sort of an increased reversion, upward reversion in Housewares and Beauty. That was specific for the second quarter. And can you overlay your commentary a little bit with inventory being down 18%. I assume that the increases – the potential increase in consolidated sales in the second quarter is based on the improvements within the supply chain over the past 3 months?

Yes. Let me go to the first part of it. You are right, absolutely right. We do see some moderation in demand for Health & Home, and that’s only because it was such a big demand surge and we were able to build that with in-stock inventory and now it’s going to be more of a steady demand that we will have to fill with our kind of continual supply, which will be a less surge type of path in more of a consistent, strong growth path we hope. And so moderation from the 30% growth in the quarter, but we are still expecting growth there. So hopefully we are not getting across the idea that the growth is going the way that’s not it, it just won’t be as explosive as it was in Q1. And then in OXO and Beauty or Housewares and Beauty, all signs are going in the right direction on both of those, with store re-openings there and continued strong demand for OXO, that we – that everything is going in the right direction. On the other hand, we are being cautious as there could be re-closures in retailers and longer term more protracted impacts from COVID-19. So there is a balance there, even though we are seeing positive trends, I think there is – things can change and they are changing almost daily in this environment and we have to be cautious of that. Your second question Steve, was on inventory. Could you repeat that?

Basically, sales, I know you are not providing guidance, but if sales on a consolidated basis in the second quarter due increase on a year-over-year basis, considering that you are coming into the quarter with such low inventory, I’m assuming that the differential there for the supply chain improvements that have been made over the past 3 months.

I think that’s fair to say and inventory is low, but it’s not as low as we have been recently. We are at $275 million. We have been down as low as $250 million. So, we are actually making a little bit of progress on inventory, but we are not where we need to be and we acknowledge that, but we have got a lot of things in place that are going to get us there shortly. The capacity improvement that Julien was talking about, we improved thermometer capacity by 30% already. And then we are looking for the next amount of improvement that will come online later in the year. So I’m just making the comment to illustrate that we are making progress and our supply inventory is low, but the triple whammy that Julien mentioned is real. Coming off of Chinese New Year and COVID, and then big demand surges on top of that have – are a huge thing to overcome and I feel like we have done pretty well.

I got it. Thank you again. I’ll take the balance offline.

Thank you.

Great.

At this time, we have reached the end of our question-and-answer session, and I will turn the call back over to Mr. Mininberg for his closing remarks.

Thank you, operator and thank you to everyone for being with us on the call today. We very much appreciate your support, and we look forward to speaking with many of you later today, and also in the coming weeks. Thanks again. Very much appreciate and transformation rolls on.

Thank you everyone. This concludes today’s conference. You may now disconnect your lines at this time and thank you for your participation.